Bursera schlechtendalii (Burseraceae) has shown antitumor activity against the 9KB (adenocarcinoma of nasal pharynx) test system. Two new lignans isolated from the biologically active plant fraction were identified as (—)‐trans‐2‐(3″,4″,5″‐trimethoxy‐benzyl)‐3‐(3′,4′‐methylenedioxybenzyl)butyrolactone and (—)‐trans ‐ 2 ‐ (3″,4″ ‐ dimethoxybenzyl) ‐ 3 ‐ (3′,4′ ‐ methylenedioxybenzyl)butyrolactone. In addition, the triterpene α‐amyrin was isolated from the active fraction.
- Antitumor activity—isolation and structure determination of two lignans from Bursera schlechtendalii
- Bursera schlechtendalii (Burseraceae)—isolation and structure determination of two new lignans
- Lignans—isolated from Bursera schlechtendalii, structure determination
- α‐Amyrin—isolated from Bursera schlechtendalii
ASJC Scopus subject areas
- Pharmaceutical Science